Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis
I Avgerinos, T Michailidis, A Liakos… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aim To assess the efficacy and safety of oral semaglutide, a novel glucagon‐like peptide‐1
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis
I Avgerinos, T Michailidis, A Liakos… - Diabetes, obesity & …, 2020 - pubmed.ncbi.nlm.nih.gov
Aim To assess the efficacy and safety of oral semaglutide, a novel glucagon-like peptide-1
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
Oral semaglutide for type 2 diabetes
I Avgerinos, A Liakos, E Bekiari, DR Matthews… - 2019 - ikee.lib.auth.gr
Aim To assess the efficacy and safety of oral semaglutide, a novel glucagon‐like peptide 1
receptor agonist, for patients with type 2 diabetes mellitus. Methods We searched Medline …
receptor agonist, for patients with type 2 diabetes mellitus. Methods We searched Medline …
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.
I Avgerinos, T Michailidis, A Liakos… - Diabetes, Obesity & …, 2019 - europepmc.org
Aim To assess the efficacy and safety of oral semaglutide, a novel glucagon-like peptide-1
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
receptor agonist, for patients with type 2 diabetes. Methods We searched Medline, Embase …
[PDF][PDF] Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis
MD Ioannis Avgerinos, MD Theodoros Michailidis… - researchgate.net
Aim: To assess the efficacy and safety of oral semaglutide, a novel glucagon-like peptide-1
receptor agonist, for patients with type 2 diabetes. Methods: We searched Medline, Embase …
receptor agonist, for patients with type 2 diabetes. Methods: We searched Medline, Embase …
Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis.
I Avgerinos, T Michailidis, A Liakos… - Diabetes, Obesity & …, 2020 - search.ebscohost.com
Aim: To assess the efficacy and safety of oral semaglutide, a novel glucagon‐like peptide‐1
receptor agonist, for patients with type 2 diabetes. Methods: We searched Medline, Embase …
receptor agonist, for patients with type 2 diabetes. Methods: We searched Medline, Embase …